强化俯卧位治疗对COVID-19相关ARDS插管患者结局的影响
本研究为一项大型国际观察性研究的辅助分析,纳入法国、比利时和瑞士149个ICU中入住ICU 48小时内接受俯卧位的插管COVID-19相关ARDS患者。强化俯卧位定义为48小时内累计俯卧位时间超过32小时,标准俯卧位为32小时或以下;主要终点为60天死亡率。强化俯卧位组(n=79)中位俯卧位时间36小时,标准俯卧位组(n=674)为16小时;60天死亡率39.2% vs 38.7%(p=0.93),28天和90天死亡率及28天无机械通气天数两组相似。经IPCW后60天死亡率无显著差异(完整病例分析HR 0.95 [0.52-1.74],p=0.87;多重插补分析HR 1.1 [0.77-1.57],p=0.61)。
要点
- 在COVID-19相关ARDS插管患者中,入住ICU后48小时内累计俯卧位超过32小时(强化组)与32小时或以下(标准组)相比,60天死亡率39.2% vs 38.7%,p=0.93。
- 经IPCW校正后,60天死亡率无显著差异:完整病例分析HR 0.95(95%CI 0.52-1.74),p=0.87;多重插补分析HR 1.1(95%CI 0.77-1.57),p=0.61。
- 28天和90天死亡率以及28天无机械通气天数在强化俯卧位组与标准俯卧位组间相似。
- 强化俯卧位组(n=79)中位俯卧位时间36小时,标准俯卧位组(n=674)中位16小时,均指入住ICU后48小时内累计时间。
- 俯卧位推荐每日16小时;本研究将48小时内累计超过32小时定义为强化俯卧位,32小时或以下为标准俯卧位。
适用人群与场景
- 法国、比利时和瑞士149个ICU中,入住ICU 48小时内接受俯卧位的插管COVID-19相关ARDS患者。
- 本研究为大型国际观察性研究的辅助分析,纳入2137例插管患者中753例接受俯卧位者。
诊断标准与关键阈值
- 俯卧位推荐每日16小时;强化俯卧位定义为入住ICU后48小时内累计俯卧位时间超过32小时,标准俯卧位定义为32小时或以下。
研究设计与关键结果
- 研究类型:大型国际观察性研究的辅助分析,采用逆概率删失加权(IPCW)Cox模型及目标模拟试验方法分析数据。
- 样本量:2137例插管患者中753例在入住ICU 48小时内接受俯卧位;强化俯卧位组n=79,标准俯卧位组n=674。
- 干预与对照:强化俯卧位(48小时内累计>32小时)vs 标准俯卧位(≤32小时)。
- 主要终点:60天死亡率强化组39.2% vs 标准组38.7%(p=0.93)。
- 经IPCW校正后60天死亡率无显著差异:完整病例分析HR 0.95(95%CI 0.52-1.74),p=0.87;多重插补分析HR 1.1(95%CI 0.77-1.57),p=0.61。
- 次要终点:28天和90天死亡率以及28天无机械通气天数两组相似。
证据类型、等级与局限
- 证据类型:国际多中心观察性研究的辅助分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在COVID-19相关ARDS插管患者中,入住ICU后48小时内强化俯卧位较标准俯卧位未提供生存获益。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Previous retrospective research has shown that maintaining prone positioning (PP) for an average of 40 h is associated with an increase of survival rates in intubated patients with COVID-19-related acute respiratory distress syndrome (ARDS). This study aims to determine whether a cumulative PP duration of more than 32 h during the first 2 days of intensive care unit (ICU) admission is associated with increased survival compared to a cumulative PP duration of 32 h or less.
METHODS: This study is an ancillary analysis from a previous large international observational study involving intubated patients placed in PP in the first 48 h of ICU admission in 149 ICUs across France, Belgium and Switzerland. Given that PP is recommended for a 16-h daily duration, intensive PP was defined as a cumulated duration of more than 32 h during the first 48 h, whereas standard PP was defined as a duration equal to or less than 32 h. Patients were followed-up for 90 days. The primary outcome was mortality at day 60. An Inverse Probability Censoring Weighting (IPCW) Cox model including a target emulation trial method was used to analyze the data.
RESULTS: Out of 2137 intubated patients, 753 were placed in PP during the first 48 h of ICU admission. The intensive PP group (n = 79) had a median PP duration of 36 h, while standard PP group (n = 674) had a median of 16 h during the first 48 h. Sixty-day mortality rate in the intensive PP group was 39.2% compared to 38.7% in the standard PP group (p = 0.93). Twenty-eight-day and 90-day mortality as well as the ventilator-free days until day 28 were similar in both groups. After IPCW, there was no significant difference in mortality at day 60 between the two-study groups (HR 0.95 [0.52-1.74], p = 0.87 and HR 1.1 [0.77-1.57], p = 0.61 in complete case analysis or in multiple imputation analysis, respectively).
CONCLUSIONS: This secondary analysis of a large multicenter European cohort of intubated patients with ARDS due to COVID-19 found that intensive PP during the first 48 h did not provide a survival benefit compared to standard PP.
参考来源
- Le Terrier C, Walter T, Lebbah S, et al. Impact of intensive prone position therapy on outcomes in intubated patients with ARDS related to COVID-19. Ann Intensive Care. 2024. PMID: 38935175. doi:10.1186/s13613-024-01340-z
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。